Vaccines: Soberana 02 to be tested on 24,000 people in Iran
Some 100,000 doses arrived in Tehran in March for the testing. Last Saturday, Soberana 02 obtained permission for clinical trials after its effectiveness and safety was assessed by the Research Ethics Working Group of the Iranian Ministry of Health.